About this trial
Cardiovascular disease (CVD) causes at least 1.8 million European deaths annually, exceeding fatalities from cancer, chronic respiratory disease, and diabetes. Consequently, the fight against CVD has become the main priority of the World Health Organization. In the pursuit of understanding and treating CVD, cardiac magnetic resonance imaging (CMR) has remained the only modality capable of providing a comprehensive assessment of the heart's function and structure without harmful radiation. Unfortunately, current CMR systems remain too slow, too complex, require highly trained specialists and, as such, have presented a barrier to a wider adoption of CMR. The aim of CARDIO-IRM is to unleash the full potential of CMR to transform patient trajectories by introducing a fast, one-click, fully automated, and comprehensive imaging pipeline applicable to diagnosis, prognosis, and therapy selection in cardiology.
Eligibility criteria
Qualifiers
Adult patient (over 18 years of age) requiring an MRI scan as part of their care.
Male or female.
Affiliated or beneficiary of a social security scheme
Having given his/her oral no objection after having read the information note
Disqualifiers
Patient unable to give oral consent (guardianship, non-French speaker, etc.)
Patient deprived of liberty
Patient who does not meet the specific eligibility criteria for an MRI examination: pregnant women, known pathology that may interfere with acquisition (e.g. Parkinson's disease), absolute or relative contraindication to an MRI examination
Patient participating in a therapeutic interventional trial or in a period of relative exclusion in relation to another protocol
Trial design
Treatments tested in this trial
- Cardiac MRI acquisition
Treatment groups
Sponsors and collaborators
University Hospital, Bordeaux
Lead sponsor
Grant Agreement ERC SMHEART
Collaborator